Cupric and Ferric Ions Inactivate HIV
- 1 March 1996
- journal article
- Published by Mary Ann Liebert Inc in AIDS Research and Human Retroviruses
- Vol. 12 (4), 333-336
- https://doi.org/10.1089/aid.1996.12.333
Abstract
Human immunodeficiency virus (HIV-1) was inactivated by either cupric or ferric ions when the virus was free in solution and also 3 hr after cell infection. Fifty percent inactivation of cell-free HIV was achieved with Cu(II) at a concentration between 0.16 and 1.6 mM, or by 1.8 to 18 mM Fe(III). Thus, the dose to inactivate 50% of infectious HIV (D50) by Cu(II) or Fe(III) is higher than that reported for glutaraldehyde (0.1 mM); between the D50 reported for sodium hypochlorite (1.3 mM) and sodium hydroxide (11.5 mM), and significantly lower than that required for HIV inactivation by ethanol (360 mM). Treatment of infected cells for 30 min at 20 degrees C with 6 mM Cu(II) or Fe(III) completely inhibited the formation of syncytia and the synthesis of virus-specific p24 antigen in HIV-infected cells, while still preserving cell viability. The virucidal properties of cupric and ferric ions could be exploited for the development of novel virucidal formulations efficient against HIV.Keywords
This publication has 17 references indexed in Scilit:
- Increased 8-Hydroxydeoxyguanosine in Kidney and Liver of Rats Continuously Exposed to CopperToxicology and Applied Pharmacology, 1994
- Induction of oxidative single- and double-strand breaks in DNA by ferric citrateFree Radical Biology & Medicine, 1993
- Iron-mediated DNA damage: Sensitive detection of DNA strand breakage catalyzed by ironJournal of Inorganic Biochemistry, 1992
- Interaction of copper with DNA and antagonism by other metalsToxicology and Applied Pharmacology, 1991
- Copper inhibits the protease from human immunodeficiency virus 1 by both cysteine-dependent and cysteine-independent mechanisms.Proceedings of the National Academy of Sciences of the United States of America, 1991
- Simple, Rapid, Quantitative, Syncytium-Forming Microassay for the Detection of Human Immunodeficiency Virus Neutralizing AntibodyAIDS Research and Human Retroviruses, 1987
- Stability and Inactivation of HTLV-III/LAV Under Clinical and Laboratory EnvironmentsJama-Journal Of The American Medical Association, 1986
- Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV)Journal of Immunological Methods, 1985
- INACTIVATION OF LYMPHADENOPATHY ASSOCIATED VIRUS BY CHEMICAL DISINFECTANTSThe Lancet, 1984
- Copper toxicity in isolated rat hepatocytesToxicology and Applied Pharmacology, 1981